Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? von Vrieling, C, Collette, L, Fourquet, A, Hoogenraad, W.J, Horiot, J.-C, Jager, J.J, Bing Oei, S, Peterse, H.L, Pierart, M, Poortmans, P.M, Struikmans, H, Van den Bogaert, W, Bartelink, H

Volltext

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial von Jones, H, Antonini, N, Collette, L, Fourquet, A, Hoogenraad, W.J, Jager, J.J, Peterse, H.L, Poortmans, P.M, Struikmans, H, Bartelink, H

Volltext

Sentinel node biopsy in melanoma. Is it worthwhile? von Kroon, B.B.R., Jansen, L., Peterse, H.L., Hoefnagel, C.A., Olmos, R.A.Valdes, Nieweg, O.E.

Volltext

Gene expression profiling predicts clinical outcome of breast cancer von Veer, L.J. van 't, Dai, H, Vijver, H. van de, He, Y.D, Hart, A.A.M, Mao, M, Peterse, H.L, Kooy, K. van der, Marton, M.J, Witteveen, A.T, Schreiber, G.J, Kerkhoven, R.M, Roberts, C, Linsley, P.S, Bernards, R.A, Friend, S.H

Volltext